Your regular clinic mix today: 2 very high risk MN, 2 ANCA associated vasculitis, 1 IgAN, 1 recurrent FSGS after transplant, and 1 microscopic polyangiitis and the list continues. #GlomerularDiseases Penn Glomerular Center

Review by Nelson Leung and Samih H. Nasr

Classification, Etiology, and Typing of Renal Amyloidosis

buff.ly/4agwo9D (FREE)

Great collaborative work, led by Safak Mirioglu! İlay Berke Eleni Frangou Gema fernandez Juarez Dr Dr Kate Stevens💙 Sarah Moran Megan Griffith Ingeborg Bajema Stefanie Steiger

C3 Glomerulopathy: Novel Treatment Paradigms

doi.org/10.1016/j.ekir…

#KIRReview #C3Glomerulopathy

We are proud to share that 75% of our outstanding medical students have successfully matched with top residency programs on Match Day 2024! 🎉👩‍⚕️👨‍⚕️ Huge congratulations to each and every one of you on this remarkable achievement! 🌟 #MatchDay2024 #AUB Proud #AUB Medicine #AUB

Our 14th International Podocyte conference 2023 meeting report is out: From podocyte biology to glomerular medicine - Kidney International. Thanks to the hosts and chairs Larry Holzman & Katalin Susztak , @NephCure International Society of Glomerular Disease HCKH_Hamburg
kidney-international.org/article/S0085-…

🚨 After 3 1/2 years of work, I am very proud to share our most recent review published today in The Lancet, together with my amazing colleagues Ingeborg Bajema Annette Bruchfeld and Drs Gianna Mastroianni Kirsztajn and John Stone, focusing on AAV. authors.elsevier.com/a/1ic21V-4XL4UH

Our Yearly #Glomerular
Disease Fellows Workshop with #fellows from all over the region coming to learn about glomerular diseases!
Thank you to course
co-directors Dr Abdallah Geara & Dr Amanda Leonberg, and to all the attendees for making it extra special!
Penn Kidney

Significant progress in understanding the immunopathogenesis of ANCA-associated vasculitis (AAV) has enabled development of targeted immunotherapies. This Review describes the evolution of treatment of AAV, particularly for patients with kidney involvement bit.ly/KID0289

Terrific Penn Kidney Grand Rounds by Dr. DeOliveira Margaret DeOliveira, M.D. (GN Fellow) and Dr. Geara (Clinical Director of the Glomerular Disease Program) on IgA Nephropathy and New Treatments
#GlomerularDisease

Stopped for a moment on the way to work — as Penn campus looked beautiful covered with a fresh coat of snow ❄️

ANCA-associated vasculitis (AAV) belongs to a group of small vessel systemic vasculitides characterized by granulomatous and neutrophilic inflammation of various tissues. This Review describes the evolution of treatment of AAV bit.ly/KID0289

IgA nephropathy is the most prevalent primary GN worldwide. This Review proposes a comprehensive approach that tackles the different targets in the pathophysiology of IgA nephropathy according to their relevance in the individual patient bit.ly/JASN0242

fernando fervenza

Original Article: A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy (ENVISION) nej.md/3tN64Dx

Editorial: APRIL — Springtime for New IgA Nephropathy Therapy? nej.md/3vmzEAE

#Nephrology

KDIGO is pleased to announce the publication of the 2024 Clinical Practice Guideline for the Management of Lupus Nephritis, published today in the January 2024 issue of Supplement to Kidney International, with an Executive Summary published in the main pages of the journal.

Read…

🎄 Just before the new year, we should look at the post hoc subgroup analysis of the BLISS-LN trial published by NDT!

#lupus #lupus nephritis Hans-Joachim Anders Prof Liz Lightstone PhD FRCP FISN 🇬🇧🇮🇱🇺🇦💙💜 Brad H Rovin

A brief 🧵 by Safak Mirioglu

🔓doi.org/10.1093/ndt/gf…

Reliable prediction tools are needed to personalize treatment in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. This study shows the updated score optimizes clinicopathologic prognostication for clinical practice and trials bit.ly/JASN0274

Late breaking at #ASH23 :

The addition of subcutaneous daratumumab to bortezomib, lenalidomide, and dexamethasone therapy and lenalidomide maintenance therapy had a significant benefit on progression-free survival among patients with multiple myeloma. Full PERSEUS trial results:

Congratulations to everyone in the fellowship match! We are thrilled to welcome these wonderful physicians to the Penn Kidney family for #Nephrology #Fellowship in 2024!
⭐️🫘🎉

#Belimumab in #lupusnephritis , effective in preventing #LN flares too??

Great review of emerging #LN treatment, role of belimumab & more by Subashri

#KIReportsCommunity Int Society of Nephrology @academicCME @NephTwitter

kireportscommunity.org/post/belibumab…